Male | Female | Athletes vs controls | |||||
---|---|---|---|---|---|---|---|
Athletes (n = 49) | Controls (n = 42) | p-value | Athletes (n = 44) | Controls (n = 30) | p-value | ||
LVEF, % | 56 ± 5 | 60 ± 5 | 0.004 | 58 ± 5 | 61 ± 4 | 0.003 | 0.001 |
LV mass index, g/m2 | 66 ± 10 | 49 ± 10 | 0.001 | 55 ± 8 | 40 ± 8 | 0.001 | 0.001 |
LVEDVI, ml/m2 | 109 ± 13 | 90 ± 15 | 0.001 | 98 ± 15 | 81 ± 9 | 0.001 | 0.001 |
LVESVI, ml/m2 | 47 ± 8 | 36 ± 8 | 0.001 | 41 ± 8 | 31 ± 5 | 0.001 | 0.001 |
LVSV, ml/m2 | 61 ± 8 | 53 ± 9 | 0.001 | 57 ± 10 | 50 ± 7 | 0.001 | 0.001 |
RVEF, % | 52 ± 6 | 54 ± 5 | 0.201 | 54 ± 4 | 57 ± 5 | 0.013 | 0.034 |
RVEDVI, ml/m2 | 110 ± 15 | 82 ± 17 | 0.001 | 92 ± 16 | 72 ± 11 | 0.001 | 0.001 |
RVESVI, ml/m2 | 53 ± 11 | 38 ± 9 | 0.001 | 42 ± 8 | 31 ± 7 | 0.001 | 0.001 |
RVSVI, ml/m2 | 58 ± 9 | 44 ± 10 | 0.001 | 50 ± 9 | 41 ± 6 | 0.001 | 0.001 |
LAAI, cm2/m2 | 14 ± 2 | 12 ± 2 | 0.001 | 14 ± 2 | 13 ± 2 | 0.349 | 0.001 |
RAAI, cm2/m2 | 13 ± 2 | 12 ± 2 | 0.002 | 11 ± 2 | 10 ± 2 | 0.489 | 0.012 |
LGE present* | 17 (35) | 2 (5) | 0.001 | 18 (41) | 0 | 0.001 | 0.001 |
Pericardial effusion | 1 (2) | 5 (12) | 0.059 | 15 (34) | 16 (53) | 0.100 | 0.068 |